These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 26749781

  • 1. Risk Factors in the Development of Oral Bisphosphonate-induced Osteonecrosis.
    Reiss S, Sultan D.
    N Y State Dent J; 2015 Nov; 81(6):30-3. PubMed ID: 26749781
    [Abstract] [Full Text] [Related]

  • 2. Dramatic osteonecrosis of the jaw associated with oral bisphosphonates, periodontitis, and dental implant removal.
    Fernández Ayora A, Herion F, Rompen E, Reginster JY, Magremanne M, Lambert F.
    J Clin Periodontol; 2015 Feb; 42(2):190-5. PubMed ID: 25327450
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW, Green JG, Bhattacharyya I, Cohen DM.
    J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
    [No Abstract] [Full Text] [Related]

  • 4. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O, Fusco V, Matranga D, Solazzo L, Gabriele M, Gaeta GM, Favia G, Sprini D, Peluso F, Colella G, Vescovi P, Campisi G.
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [Abstract] [Full Text] [Related]

  • 5. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
    Taylor T, Bryant C, Popat S.
    Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T.
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [Abstract] [Full Text] [Related]

  • 10. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J.
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [Abstract] [Full Text] [Related]

  • 11. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate.
    Ulmner M, Jarnbring F, Törring O.
    J Oral Maxillofac Surg; 2014 Jan; 72(1):76-82. PubMed ID: 23992777
    [Abstract] [Full Text] [Related]

  • 17. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.
    Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A.
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1937.e1-8. PubMed ID: 25234534
    [Abstract] [Full Text] [Related]

  • 18. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [Abstract] [Full Text] [Related]

  • 19. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 20. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
    Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C.
    J Craniomaxillofac Surg; 2011 Jun; 39(4):272-7. PubMed ID: 20580566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.